Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Diabetol Metab Syndr. 2010 Jul 27;2:51. doi: 10.1186/1758-5996-2-51.
Lipoprotein (a) (LP (a) is an independent cardiovascular risk factor that is not widely studied in people of sub-Saharan African origin. The aim of this report is to determine the frequency of occurrence of elevated Lp (a) and possible relationship with total cholesterol (TCHOL), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), C reactive protein (CRP) and serum uric acid (SUA).
This is a cross sectional study carried out in 200 Nigerian patients with type 2 DM and 100 sex and age matched healthy Controls aged between 32-86 years. We determined the frequency of occurrence of elevated Lp (a) levels in the study subjects and compared clinical and biochemical variables between type 2 diabetic patients and non-diabetic patients. Clinical and biochemical parameters were also compared between subjects with type 2 DM who had elevated LP (a) and normal LP (a) levels. Long term glycaemic control using glycosylated haemoglobin was determined and compared in the study subjects. Test statistics used include chi square, correlation coefficient analysis and Student's t test.
The mean Lp(a) concentration differed significantly between type 2 diabetic patients and the Control subjects (18.7 (5.8) mg/dl vs 23 (6.8) mg/dl, 0.00001). Similarly, the prevalence of high LP (a) levels in type 2 DM patients was significantly higher than that of the Control subjects (12.5% vs 4%, p-0.019). The mean levels of the lipid profile parameters (TCHOL, LDL-C, TG, LDL/HDL) and CRP were significantly higher in DM patients than in the Control subjects. The mean LP (a) levels were comparable in both sexes and in DM subjects with and without hypertension. TG was the only parameter that differed significantly between subjects with elevated Lp (a) levels and those with normal Lp (a) levels. There was a significant positive correlation (r) between Lp(a) levels and TG, LDL-C. TCHOL, LDL/HDL and uric acid. No association was found between Lp(a) and clinical parameters such as age and anthropometric indices.
We have showed that Lp (a), CRP and other CVS risk factors cluster more in patients with DM than non DM patients. Serum Lp (a) levels are not associated with anthropometric and glycaemic indices.
脂蛋白 (a) (LP (a)) 是一种独立的心血管风险因素,在撒哈拉以南非洲人群中尚未得到广泛研究。本报告的目的是确定升高的 Lp (a) 的发生率,并探讨其与总胆固醇 (TCHOL)、高密度脂蛋白胆固醇 (HDL-C)、低密度脂蛋白胆固醇 (LDL-C)、甘油三酯 (TG)、C 反应蛋白 (CRP) 和血清尿酸 (SUA) 的可能关系。
这是一项在 200 名尼日利亚 2 型糖尿病患者和 100 名年龄和性别匹配的健康对照者中进行的横断面研究,年龄在 32-86 岁之间。我们确定了研究对象中升高的 Lp (a) 水平的发生率,并比较了 2 型糖尿病患者和非糖尿病患者的临床和生化变量。还比较了 2 型糖尿病患者中 Lp (a) 升高和正常的 LP (a) 水平之间的临床和生化参数。使用糖化血红蛋白来确定和比较研究对象的长期血糖控制情况。使用卡方检验、相关系数分析和学生 t 检验进行统计检验。
2 型糖尿病患者和对照组之间的 Lp(a) 浓度差异有统计学意义 (18.7 (5.8) mg/dl vs 23 (6.8) mg/dl,0.00001)。同样,2 型糖尿病患者中高 LP (a) 水平的患病率明显高于对照组 (12.5% vs 4%,p-0.019)。血脂谱参数 (TCHOL、LDL-C、TG、LDL/HDL) 和 CRP 的平均水平在糖尿病患者中明显高于对照组。在男性和女性中,以及在有或没有高血压的 DM 患者中,LP (a) 水平相似。在 Lp (a) 水平升高的患者和 Lp (a) 水平正常的患者之间,只有 TG 这一参数存在显著差异。Lp(a) 水平与 TG、LDL-C、TCHOL、LDL/HDL 和尿酸呈显著正相关 (r)。Lp(a) 与年龄和人体测量学指数等临床参数之间没有关联。
我们已经表明,Lp (a)、CRP 和其他心血管风险因素在糖尿病患者中比非糖尿病患者更集中。血清 Lp (a) 水平与人体测量学和血糖指数无关。